2023
De Coninck S, De Smedt R, Lintermans B, Reunes L, Kosasih HJ, Reekmans A, Brown LM, Van Roy N, Palhais B, Roels J, Van der Linden M, Van Dorpe J, Ntziachristos P, van Delft FW, Mansour MR, Pieters T, Lammens T, De Moerloose B, de Bock CE, Goossens S and Van Vlierberghe P. (2023). Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma. Haematologica, in press. DOI: 10.3324/haematol.2023.283981. PMID: 37941480
Vanhooren J*, Dobbelaere R*, Derpoorter C*, Deneweth L*, Van Camp L, Uyttebroeck A, De Moerloose B and Lammens T. (2023). CAR-T in the treatment of acute myeloid leukemia: barriers and how to overcome them. Hemasphere 7 (9): e937. DOI: 10.1097/HS9.0000000000000937. (* These authors contributed equally). PMID: 37674860
Förster A, Davenport C, Duployez N, Erlacher M, Ferster A, Fitzgibbon J, Göhring G, Hasle H, Jongmans MC, Kolenova A, Kronnie G, Lammens T, Mecucci C, Mlynarski W, Niemeyer CM, Sole F, Szczepanski T, Waanders E, Biondi A, Wlodarski M, Schlegelberger B and Ripperger T. (2023). European standard clinical practice – Key issues for the medical care of individuals with familial leukemia. Eur J Med Genet. 66(4): 104727. Doi: 10.1016/j.ejmg.2023.104727. PMID: 36775010
Van Trimpont M, Schalk AM, De Visser Y, Nguyen HA, Reunes L, Vandemeulebroecke K, Peeters E, Su Y, Lee H, Lorenzi PL, Chan WK, Mondelaers V, De Moerloose B, Lammens T, Goossens S, Van Vlierberghe P and Lavie A. (2023). In vivo stabilization of a less toxic asparaginase variant leads to a durable anti-tumor response in acute Leukemia. Haematologica 108 (2): 409–419. DOI:10.3324/haematol.2022.281390. PMID: 35979719
2022
De Vos N, Hofmans M, Lammens T, De Wilde B, Van Roy N and De Moerloose B. (2022). Targeted therapy in juvenile myelomonocytic leukemia: Where are we now? Ped. Blood Cancer, in press. DOI: 10.1002/pbc29930. PMID: 36094370
Derpoorter C, Van Paemel R, Vandemeulebroecke K, Vanhooren J, De Wilde B, Laureys G and Lammens T. (2022). Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer. Pediatric Hematol. Oncol. In press. DOI: 10.1080/08880018.2022.2101723. PMID: 35876323
Feenstra LR, R. Gehring R, van Geijswijk IM, König T, Prinsen HCMT, Vandemeulebroecke K, Lammens T, Krupa A, and Teske E. (2022). Evaluation of PEG-L-Asparaginase in asparagine suppression and anti-drug antibody development in healthy beagle dogs: A multi-phase preclinical study. The Vet J., in press. DOI: 10.1016/j.tvjl.2022.105854. PMID: 35781075
Luijts T, Elliott K, Siaw JT, Van de Velde J, Beyls E, Claeys A, Lammens T, Larsson E, Willaert W, Vral A and Van den Eynden J. (2022). A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues. Sci. Rep. 12: 10322. DOI: 10.1038/s41598-022-14240-8. PMID: 35725896
Vanhooren J, Van Camp L, Depreter B, de Jong M, Uyttebroeck A, Van Damme A, Dedeken L, Dress MF, van der Werff ten Bosch J, Hofmans M, Philippé J, De Moerloose B and Lammens T. (2022). Deciphering the non-coding landscape of pediatric acute myeloid leukemia. Cancers 14: 2098. DOI: 10.3390. PMID: 35725896
Diez-Fraile A, De Ceulaer J, Derpoorter C, Spaas C, De Backer T, Lamoral P, Abeloos J and Lammens T. (2022). Tracking the molecular fingerprint of head and neck cancer for recurrence detection in liquid biopsis. Int. J. Mol. Sci. 23: 2403. DOI: 10.3390/ijms23052403. PMID: 35269544